detekdi dini ca. pd dr. indra-onko

45
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 1/45 B REA ST CANCER Epidemiologi Penyebab dan Faktor Resiko Gejala dan Tanda Stadium Tindak Lanjut Training 5 Hari Dokter-Bidan-Kader Female Cancer Programme FKUI-RSCM/ YKI DKI dan Dinas Kesehatan DKI Jakarta Indra Hidayah Siregar/  Ahmad Kurnia Divisi Bedah Onkologi FKUI/RSCM Jakarta Departemen Bedah FKUI/RSCM Jakarta

Upload: reganjm

Post on 02-Jun-2018

223 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 1/45

BREAST CANCEREpidemiologi

Penyebab dan Faktor Resiko

Gejala dan Tanda

Stadium

Tindak Lanjut

Training 5 Hari Dokter-Bidan-Kader

Female Cancer Programme FKUI-RSCM/

YKI DKI dan Dinas Kesehatan DKI Jakarta

Indra Hidayah Siregar/

 Ahmad Kurnia

Divisi Bedah Onkologi FKUI/RSCM Jakarta

Departemen Bedah FKUI/RSCM Jakarta

Page 2: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 2/45

Ca mamae sin std IIIb

Page 3: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 3/45

Ca mamae dex s td IIIb

Page 4: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 4/45

Post m astectomy a/I Ca mamae dex std

IIIb-   b ilateral std IV

Page 5: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 5/45

 

Page 6: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 6/45

In t roduct ion

• Most common female cancer

•  Accounts for 32% of all female cancer

• 211,300 new cases yearly and rising

• 40,000 deaths yearly

US data

Indonesia ?

Page 7: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 7/45

• Profil Kesehatan Indonesia 2008 :

 – Urutan pertama (2004-2007)

 – 8277 kasus (16,85%)

 – Insidens di Indonesia : 36,2 per 100.000 pr

dengan angka kematian : 18,6 per 100.000

pr. (20.052 kasus). Data oleh GlobalBurden of Cancer, 2008.

Page 8: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 8/45

• RSCM :

 – Penelitian terhadap 300 pasien  bedah,

(1989-1992) terbanyak : kanker payudaralanjut lokal (66%).

 – 1998-2002 : 27,5%, tetapi stadium IV

meningkat (47,4%).

 – US : KPLL < 5%

Page 9: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 9/45

Page 10: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 10/45

10 KANKER TERBANYAK DIINDONESIA

Number  ICD  Location  Relative Frequency 

1. 2. 3. 4. 5. 6. 7. 

8. 9. 10. 

180 174 173 147 

183 196 

154 171 193 

Cervix Women's breast 

Skin Nasopharynx 

Unknown Ovaries 

Lymphoid nodes 

Rectum Soft tissue 

Thyroid 

18,41 %11,57 %8,24 %6,15 %5,16 %4,94 %4,91 %

4,42 %3,50 %3,38 %

Source: Bulletin of Pathology Based Cancer Registry, BRK-IAP, No. 4, 1989.

Page 11: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 11/45

Page 12: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 12/45

BREAST CANCERAge-speci fic incidence (per 100,000)

United

States

England

and Wales

Italy

France

Japan

Incidence rates

20 25 30 35 40 45 50 55 60 65 70 75 80 85+

24 29 34 39 44 49 54 59 64 69 74 79 84

420400

300

200

100

0

Age

 Adapted from New Horizons in Cancer Management, SRI International, 1990.

Page 13: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 13/45

BREAST CANCERRisk factors

Female

History of breast cancer

Family history of breast cancer, especially in

first-degree relatives : 1,8 x

Benign breast “cancer”/ atypical hyperplasia : 5 x

Early menarche : 1,7-3,4 x, late menopause : 1,5 x

Late first pregnancy/no pregnancy : 1,5-4 x

Exogenous estrogens

Radiation ( < 16 yo:100x, 20-29yo:6x, >30yo : -)

? Diet, alcohol

Page 14: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 14/45

BREAST CANCERIncidence of major histo logic types

Percent of all Infiltrating Carcinomas

78%

9%4% 3% 5%

1%

Ductal Lobular Medullary Colloid Comedo Papillary

 Adapted from McDivitt R et al, 1967.

Page 15: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 15/45

Range ofDuctal Carcinoma in situ

15   I   l   l  u  s   t  r  a   t   i  o  n   ©

   M  a  r  y   K .

   B  r  y  s  o  n

Page 16: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 16/45

Detection

Page 17: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 17/45

American Cancer Soc iety

• Skrining kanker payudara sedini

mungkin :

 – Pr > 20 thn : sadari tiap bulan

 – Pr > 20-40 thn : memeriksakan diri ke

dokter tiap 3 tahun

 – Pr > 40 thn : memeriksakan diri ke doktertiap tahun

 – Pr 35-40 thn : base line mammografi

 – Pr > 50 thn : mammografi tiap tahun.

Page 18: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 18/45

Waktu mamografi

Sebaiknya dikerjakan pada :

• Wanita usia diatas 35/40 tahun sebagaibaseline

• Wanita dengan faktor risiko tinggi

• 7-10 hari masa haid

Page 19: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 19/45

Palpable mass

Thickening

Pain

Mass or pain

in the axilla

Nipple discharge

Nipple retraction

Edema or erythema

of the skin

BREAST CANCER/LOCAL MANIFESTATIONS

Signs and symptoms at presentat ion

Page 20: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 20/45

Page 21: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 21/45

Nipp le retracted

Page 22: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 22/45

Nipp le dischrge

Page 23: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 23/45

Peau d’orange 

H i /

Page 24: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 24/45

Hyperemis /

mast i tis carc inomatous

Page 25: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 25/45

T 4

Ulkus

Peau d’Orange 

Nipple retracted

Mass

Page 26: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 26/45

Page 27: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 27/45

Lymph nodes

Skin

Liver

Kidney

Brain

Pulmonary

Bone

BREAST CANCER/DISTANT MANIFESTATIONS

Signs and symptom s at presentat ion

Page 28: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 28/45

Distan t Metastase

• Paru batuk, sesak,foto thorax

• Hati hepatomegali, USG hepar

• Tulang nyeri ketok,foto polos, bone scan

• Otak nyeri kepala hebat, scan

Page 29: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 29/45

What Mammograms Show

Two of the most important mammographicindicators of breat cancers

– Masses

– Microcalcifications:  Tiny flecks of calcium – likegrains of salt – in the soft tissue of the breastthat can sometimes indicate an early cancer.

29

Page 30: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 30/45

Detection of Malignant Masses

Malignant masses have a more spiculated

appearance

30

malignant

benign

Page 31: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 31/45

Mammogram –  Difficult Case

31

• Heterogeneously dense breast

• Cancer can be difficult todetect with this type of

breast tissue

• The fibroglandular tissue(white areas) may hide thetumor

• The breasts of youngerwomen contain more glandsand ligaments resulting indense breast tissue

Page 32: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 32/45

Mammogram –  Easier Case

32

• With age, breast tissue

becomes fattier and hasfewer glands

• Cancer is relatively easyto detect in this type ofbreast tissue

Page 33: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 33/45

Page 34: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 34/45

Page 35: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 35/45

 

Page 36: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 36/45

BREAST CANCER

TNM stage grouping

Stage 0 Tis. N0 M0

Stage I T1 N0 M0

Stage IIA T0, T1 N1 M0

T2 N0 M0Stage IIB T2 N1 M0

T3 N0 M0

Stage IIIA T0, T1, T2 N2 M0

T3 N1, N2 M0Stage IIIB Any T N3 M0

T4 Any N M0

Stage IV Any T Any N M1

Page 37: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 37/45

BREAST CANCERSurvival by s tage

Stage 0

Stage I

Stage IIA

Stage IIB

Stage IIIA

Stage IIIB

Stage IV

Percent surviving

100

80

60

40

20

0

1 2 3 4 5 6

 Years after diagnosis

Page 38: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 38/45

BREAST CANCER SCREENING PATH

Fine-needle aspiration

biopsy

Breast self-examination

Palpable

mass

(not cyst)

Diagnostic imaging

- mammogram

- ultrasound

- compression magnification filmNormal

Physical examination(yearly)

Screening mammogram(guidelines)

Suspicious Equivocal

Equivocal or

suspicious

Probably

benignCyst

Short-term

follow-upAspiration

Normal

 –  +

Page 39: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 39/45

BREAST CANCER DIAGNOSIS PATH

Evaluation

for

biopsy

Cyst

aspiration

Fine-needle aspiration

biopsy

Needle

localization

Palpable

mass

Ductal

carcinoma

in situ

Invasive

cancer

Lobular

carcinoma

in situ

BenignInsufficientevaluation,rebiopsy

If persistent,

short-term

follow-up

with surgeon

Continued

appropriate

screening

Cyst Normal

Nonpalpable

mass

Treatment Path

Page 40: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 40/45

BREAST CANCERTherapeut ic opt ions

Surgery

Radiotherapy

Chemotherapy

Hormonal therapy

Immunotherapy

New therapies

Supportive care

Page 41: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 41/45

BREAST CANCERSurgical opt ions I

Local excision

mass 

mass

Wide excision

…... Quadrantectomy 

Page 42: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 42/45

BREAST CANCERSurg ical op t ions II

Modified radical mastectomy Radical mastectomy

Incision

Excised area

mass mass

nodes 

nodes

Excised area

Page 43: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 43/45

Page 44: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 44/45

Page 45: Detekdi Dini CA. Pd Dr. Indra-Onko

8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko

http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 45/45